480 related articles for article (PubMed ID: 21840487)
21. JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway.
Wang W; Li F; Xu Y; Wei J; Zhang Y; Yang H; Gao B; Yu G; Fang D
J Biol Chem; 2018 Jul; 293(28):11067-11075. PubMed ID: 29789426
[TBL] [Abstract][Full Text] [Related]
22. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
23. Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts.
Shieh AC; Rozansky HA; Hinz B; Swartz MA
Cancer Res; 2011 Feb; 71(3):790-800. PubMed ID: 21245098
[TBL] [Abstract][Full Text] [Related]
24. LIF mediates proinvasive activation of stromal fibroblasts in cancer.
Albrengues J; Bourget I; Pons C; Butet V; Hofman P; Tartare-Deckert S; Feral CC; Meneguzzi G; Gaggioli C
Cell Rep; 2014 Jun; 7(5):1664-1678. PubMed ID: 24857661
[TBL] [Abstract][Full Text] [Related]
25. Rho-ROCK signaling regulates tumor-microenvironment interactions.
Johan MZ; Samuel MS
Biochem Soc Trans; 2019 Feb; 47(1):101-108. PubMed ID: 30559270
[TBL] [Abstract][Full Text] [Related]
26. Differential Depth Sensing Reduces Cancer Cell Proliferation via Rho-Rac-Regulated Invadopodia.
Chaudhuri PK; Pan CQ; Low BC; Lim CT
ACS Nano; 2017 Jul; 11(7):7336-7348. PubMed ID: 28654281
[TBL] [Abstract][Full Text] [Related]
27. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.
Takahashi Y; Takahashi M; Carpino N; Jou ST; Chao JR; Tanaka S; Shigeyoshi Y; Parganas E; Ihle JN
Mol Endocrinol; 2008 Jul; 22(7):1673-81. PubMed ID: 18451094
[TBL] [Abstract][Full Text] [Related]
28. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.
Boyle K; Zhang JG; Nicholson SE; Trounson E; Babon JJ; McManus EJ; Nicola NA; Robb L
Cell Signal; 2009 Mar; 21(3):394-404. PubMed ID: 19056487
[TBL] [Abstract][Full Text] [Related]
29. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion.
Wilkinson S; Paterson HF; Marshall CJ
Nat Cell Biol; 2005 Mar; 7(3):255-61. PubMed ID: 15723050
[TBL] [Abstract][Full Text] [Related]
30. The ROCK isoforms differentially regulate the morphological characteristics of carcinoma cells.
Jerrell RJ; Leih MJ; Parekh A
Small GTPases; 2020 Mar; 11(2):131-137. PubMed ID: 28650698
[TBL] [Abstract][Full Text] [Related]
31. The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology.
Sims NA
Exp Mol Med; 2020 Aug; 52(8):1185-1197. PubMed ID: 32788655
[TBL] [Abstract][Full Text] [Related]
32. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
[TBL] [Abstract][Full Text] [Related]
33. CDC42EP5/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion.
Farrugia AJ; RodrÃguez J; Orgaz JL; Lucas M; Sanz-Moreno V; Calvo F
J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32798219
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of esophageal-carcinoma cell proliferation by genistein via suppression of JAK1/2-STAT3 and AKT/MDM2/p53 signaling pathways.
Gao J; Xia R; Chen J; Gao J; Luo X; Ke C; Ren C; Li J; Mi Y
Aging (Albany NY); 2020 Apr; 12(7):6240-6259. PubMed ID: 32276266
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.
Chen X; Yang W; Deng X; Ye S; Xiao W
Mol Vis; 2020; 26():517-529. PubMed ID: 32818015
[TBL] [Abstract][Full Text] [Related]
36. PTK7-Src signaling at epithelial cell contacts mediates spatial organization of actomyosin and planar cell polarity.
Andreeva A; Lee J; Lohia M; Wu X; Macara IG; Lu X
Dev Cell; 2014 Apr; 29(1):20-33. PubMed ID: 24703874
[TBL] [Abstract][Full Text] [Related]
37. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
[TBL] [Abstract][Full Text] [Related]
38. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L; Rawal B; Nemeth JA; Haura EB
Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
[TBL] [Abstract][Full Text] [Related]
39. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
40. Actin stress fibres.
Pellegrin S; Mellor H
J Cell Sci; 2007 Oct; 120(Pt 20):3491-9. PubMed ID: 17928305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
